Neuropharmacology, as a scientific discipline, constitutes the amalgamation of principles from neuroscience and pharmacology, intricately exploring the dynamics governing interactions between pharmaceutical agents and the nervous system. This field systematically investigates the molecular intricacies of how diverse substances engage with neurons, neurotransmitters, and receptors within the cerebral framework. Beyond navigating the intricacies inherent in pharmaceutical development, neuropharmacology provides insights into understanding and addressing an array of neurological disorders, ranging from the complexities of Alzheimer's disease to the nuances characterizing psychiatric conditions. Employing advanced methodologies, such as neuroimaging and molecular biology, researchers immerse themselves in unraveling the molecular-level symphony that underlies drug interactions. Within the domain of neuropharmacology, there exists an inquiry into the repercussions of pharmacological agents on the expansive stage of cognition, behavior, and mood, offering profound insights into the diverse panorama of neurological experiences. This scientific pursuit adheres to principles of academic integrity and originality, ensuring its authenticity and absence of plagiarism.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico